Anika Therapeutics (ANIK) Acquisitions (2020 - 2021)
Anika Therapeutics' (ANIK) quarterly Acquisitions came in at $113000.0 in Q4 2021, down 84.77% year-over-year from $742000.0 in Q4 2020, and up 927.27% quarter-over-quarter from $11000.0 in Q3 2021.
Powered by 
Analysis
Anika Therapeutics (ANIK) Acquisitions (2020 - 2021) Analysis & Trends
Anika Therapeutics (ANIK) has reported Acquisitions for 2 consecutive years, with $113000.0 the latest figure, recorded in Q4 2021.
- On a quarterly basis, Acquisitions fell 84.77% year-over-year to $113000.0 in Q4 2021; TTM through Sep 2022 was $113000.0, a 89.77% decrease from a year earlier, with the FY2021 full-year figure at $476000.0, down 99.5% from the prior year.
- Acquisitions was $113000.0 for Q4 2021 at Anika Therapeutics, up from $11000.0 in the prior quarter.
- Over five years, Acquisitions peaked at $93.0 million in Q1 2020 and troughed at $2000.0 in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.16 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 437.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 195.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 16.00 Mn |
| 10 | Anika Therapeutics | 277.93 Mn | 239.52 Mn | 21.24 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 113,000.00 |
| Sep 30, 2021 | 11,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Mar 31, 2021 | 350,000.00 |
| Dec 31, 2020 | 742,000.00 |
| Jun 30, 2020 | 876,000.00 |
| Mar 31, 2020 | 92.98 Mn |